Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference11 articles.
1. Kang W, Kim K, Kim EY, Kwon KI, Bang JS, Yoon YR (2008) Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate. Eur J Clin Pharmacol 64:1027–1030
2. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) (1997) Guidance for industry. Modified release solid oral dosage forms: scale up and post approval changes (SUPAC): chemistry, manufacturing and controls, in vitro dissolution testing and in vivo bioequivalence documentation. FDA, Rockville
3. Jang DJ, Park JS, Ko HR, Jee JP, Kim JK, Kim ST, Kim CK (2005) Simultaneous determination of niflumic acid and its prodrug, talniflumate in human plasma by high performance liquid chromatography. Biomed Chromatogr 19:32–35
4. Kang W, Kim K (2009) Determination of talniflumate and niflumic acid in human plasma by liquid chromatography–tandem mass spectrometry. Anal Sci 25:571–574
5. Wilson P, Clark GW, Anselmino M, Welch NT, Singh S, Perdikis G, Hinder RA (1993) Comparison of an intravenous bolus of famotidine and Mylanta II for the control of gastric pH in critically ill patients. Am J Surg 166:621–624
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献